206 related articles for article (PubMed ID: 24586678)
1. Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
Yanai M; Rocha MA; Matolek AZ; Chintalacharuvu A; Taira Y; Chintalacharuvu K; Beenhouwer DO
PLoS One; 2014; 9(2):e89308. PubMed ID: 24586678
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils.
Ma X; Chang W; Zhang C; Zhou X; Yu F
PLoS One; 2012; 7(4):e34970. PubMed ID: 22529963
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps.
Malachowa N; Kobayashi SD; Freedman B; Dorward DW; DeLeo FR
J Immunol; 2013 Dec; 191(12):6022-9. PubMed ID: 24190656
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.
Badarau A; Rouha H; Malafa S; Logan DT; Håkansson M; Stulik L; Dolezilkova I; Teubenbacher A; Gross K; Maierhofer B; Weber S; Jägerhofer M; Hoffman D; Nagy E
J Biol Chem; 2015 Jan; 290(1):142-56. PubMed ID: 25371205
[TBL] [Abstract][Full Text] [Related]
5. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
6. [Pore-forming leukotoxins from Staphylococcus aureus: variability of the target cells and 2 pharmacological processes].
Prévost G; Colin DA; Staali L; Baba Moussa L; Gravet A; Werner S; Sanni A; Meunier O; Monteil H
Pathol Biol (Paris); 1998 Jun; 46(6):435-41. PubMed ID: 9769878
[TBL] [Abstract][Full Text] [Related]
7. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
[TBL] [Abstract][Full Text] [Related]
8. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
9. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family.
Morinaga N; Kaihou Y; Noda M
Microbiol Immunol; 2003; 47(1):81-90. PubMed ID: 12636257
[TBL] [Abstract][Full Text] [Related]
10. Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation.
Hodille E; Cuerq C; Badiou C; Bienvenu F; Steghens JP; Cartier R; Bes M; Tristan A; Plesa A; Le VT; Diep BA; Lina G; Dumitrescu O
Front Cell Infect Microbiol; 2016; 6():180. PubMed ID: 28018862
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.
Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA
Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
13. Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products.
Niemann S; Bertling A; Brodde MF; Fender AC; Van de Vyver H; Hussain M; Holzinger D; Reinhardt D; Peters G; Heilmann C; Löffler B; Kehrel BE
Sci Rep; 2018 Feb; 8(1):2185. PubMed ID: 29391581
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.
Genestier AL; Michallet MC; Prévost G; Bellot G; Chalabreysse L; Peyrol S; Thivolet F; Etienne J; Lina G; Vallette FM; Vandenesch F; Genestier L
J Clin Invest; 2005 Nov; 115(11):3117-27. PubMed ID: 16276417
[TBL] [Abstract][Full Text] [Related]
15. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.
Yoong P; Torres VJ
Nat Commun; 2015 Sep; 6():8125. PubMed ID: 26330208
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus Panton-Valentine Leukocidin triggers an alternative NETosis process targeting mitochondria.
Mazzoleni V; Zimmermann K; Smirnova A; Tarassov I; Prévost G
FASEB J; 2021 Feb; 35(2):e21167. PubMed ID: 33241563
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus leukotoxin GH promotes inflammation.
Malachowa N; Kobayashi SD; Braughton KR; Whitney AR; Parnell MJ; Gardner DJ; Deleo FR
J Infect Dis; 2012 Oct; 206(8):1185-93. PubMed ID: 22872735
[TBL] [Abstract][Full Text] [Related]
18. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
19. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.
Tromp AT; Van Gent M; Abrial P; Martin A; Jansen JP; De Haas CJC; Van Kessel KPM; Bardoel BW; Kruse E; Bourdonnay E; Boettcher M; McManus MT; Day CJ; Jennings MP; Lina G; Vandenesch F; Van Strijp JAG; Lebbink RJ; Haas PA; Henry T; Spaan AN
Nat Microbiol; 2018 Jun; 3(6):708-717. PubMed ID: 29736038
[TBL] [Abstract][Full Text] [Related]
20. Selective sensitization of human neutrophils to LukGH mediated cytotoxicity by Staphylococcus aureus and IL-8.
Janesch P; Rouha H; Weber S; Malafa S; Gross K; Maierhofer B; Badarau A; Visram ZC; Stulik L; Nagy E
J Infect; 2017 May; 74(5):473-483. PubMed ID: 28237625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
